ISPC
ISPC
NASDAQ · Health Care

Ispecimen Inc

$2.65
-0.14 (-5.02%)
As of Jun 30, 11:00 PM ET ·
Financial Highlights (FY 2026)
Revenue
24.09M
Net Income
-130,994,520
Gross Margin
1.2%
Profit Margin
-543.7%
Rev Growth
-43.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 1.2% 1.2% 46.6% 46.6%
Operating Margin -465.4% -418.9% 15.9% 13.1%
Profit Margin -543.7% -516.5% 10.7% 14.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 24.09M 42.25M 890.1K 703.7K
Gross Profit 301.2K 528.1K 415.1K 328.2K
Operating Income -112,139,304 -176,968,917 141.2K 92.5K
Net Income -130,994,520 -206,724,650 95.2K 101.7K
Gross Margin 1.2% 1.2% 46.6% 46.6%
Operating Margin -465.4% -418.9% 15.9% 13.1%
Profit Margin -543.7% -516.5% 10.7% 14.5%
Rev Growth -43.0% -43.0% +8.3% +9.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.46M 1.43M
Total Equity 1.24M 1.20M
D/E Ratio 1.18 1.19
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -111,283,487 -185,374,912 175.3K 162.6K
Free Cash Flow 124.9K 90.2K